Cellularity assessment [Interpretation] in Specimen by Flow cytometry (FC) Narrative 67127-1
LOINC Code
LOINC code | 67127-1 | ||
---|---|---|---|
name | Cellularity assessment [Interpretation] in Specimen by Flow cytometry (FC) Narrative | ||
description | This code is intended to express the distribution of cell types in a leukocyte population, and was entered as part of a leukemia/lymphoma flow study. An example result is: "Abnormal T lymphocytes 92%, normal lymphocytes <1%, granulocytes 5.7%, monocytes 1.5%, NK cells 0.7% | ||
status | ACTIVE | ||
Fully-Specified Name | |||
component | Cellularity assessment | ||
property | Imp = Impression/interpretation of study | ||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||
system | XXX | ||
scale | Nar = Narrative: Text narrative, such as the description of a microscopic part of a surgical papule test. | ||
method | Flow cytometry | ||
Additional Names | |||
short name | Cellularity assessment Spec FC-Imp | ||
Basic Attributes | |||
class | CELLMARK | ||
type | 1 Laboratory | ||
order vs. observation | Observation | ||
Associated Observations | |||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||
History/Usage | |||
test rank | 5626 of 2000 most commonly performed tests by labs in USA | ||
first released | |||
last updated | 2.73 | ||
last change type | MIN - change to field other than name | ||
Related Names | |||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.